KalVista Pharmaceuticals, Inc. today announced that six abstracts have been accepted for presentation at the American Academy of Allergy, Asthma & Immunology (AAAAI) / World Allergy Organization (WAO) ...

"Net sales increased during the fourth quarter by 41.5 percent to SEK 64.2 million, compared with the corresponding quarter of 2023. The growth and strong performance are a result of robust developmen ...

Posters will be hung up by the curriculum office on Wednesday, March 5 and will stay until 2 p.m., Thursday, March 6, 2025. Each presentation board will be labeled with a number and a category that ...

Background: Most patients diagnosed with small cell lung cancer have extensive stage disease (ES-SCLC) at presentation, portending a poor ... RT would improve the PFS from 5 months to 8 months. sample ...

Background: The efficacy and safety of neoadjuvant immunotherapy (NAI) for treating resectable locally advanced head and neck squamous cell carcinoma (LAHNSCC) remain uncertain, and the comprehensive ...

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.